These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3259246)

  • 1. Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population.
    Tribe DE; Reed DL; Lindell P; Kenealy WR; Ferguson BQ; Cybulski R; Winslow D; Waselefsky DM; Petteway SR
    J Clin Microbiol; 1988 Apr; 26(4):641-7. PubMed ID: 3259246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.
    Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J
    J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of human serum antibodies to human immunodeficiency virus (HIV) using recombinant ENV and GAG antigens.
    Kenealy W; Reed D; Cybulski R; Tribe D; Taylor P; Stevens C; Matthews T; Petteway S
    AIDS Res Hum Retroviruses; 1987; 3(1):95-105. PubMed ID: 3304356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gag.
    Marcus-Sekura CJ; Woerner AM; Klutch M; Quinnan GV
    Biochim Biophys Acta; 1988 Feb; 949(2):213-23. PubMed ID: 2449245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects.
    Manca N; di Marzo Veronese F; Ho DD; Gallo RC; Sarngadharan MG
    Eur J Epidemiol; 1987 Jun; 3(2):96-102. PubMed ID: 3497054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies directed against human immunodeficiency virus (HIV) gag proteins with specificity for conserved epitopes in HIV-1, HIV-2 and simian immunodeficiency virus.
    Niedrig M; Rabanus JP; L'Age Stehr J; Gelderblom HR; Pauli G
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2109-14. PubMed ID: 2457067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False-positive sera do not react with human immunodeficiency virus (HIV) gag-encoded recombinant antigen.
    Bukrinsky MI; Syrtsev VA; Popov SA; Barsov EV; Chaplinskas SA; Karamov EV
    J Med Virol; 1989 Jan; 27(1):72-5. PubMed ID: 2466101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliable detection of individuals seropositive for the human immunodeficiency virus (HIV) by competitive immunoassays using Escherichia coli-expressed HIV structural proteins.
    Dawson GJ; Heller JS; Wood CA; Gutierrez RA; Webber JS; Hunt JC; Hojvat SA; Senn D; Devare SG; Decker RH
    J Infect Dis; 1988 Jan; 157(1):149-55. PubMed ID: 3275722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of recombinant human immunodeficiency virus gag precursor and gag/env fusion proteins and a synthetic env peptide as diagnostic reagents.
    Shoeman RL; Young D; Pottathil R; Victor J; Conroy RR; Crowl RM; Coleman T; Heimer E; Lai CY; Ganguly K
    Anal Biochem; 1987 Mar; 161(2):370-9. PubMed ID: 3495201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serologic AIDS diagnosis with polypeptides obtained by genetic technics of the human immunodeficiency virus (HIV-1)].
    Lenz A; von Hintzenstern J; Erlwein O; Ellinger S; Bröker M; Fleckenstein B; Jahn G
    Klin Wochenschr; 1987 Nov; 65(21):1042-7. PubMed ID: 3323645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of antibodies to human immunodeficiency virus by recombinant immunoassay and Western blot techniques in HIV antibody-positive hemophiliacs.
    Ragni MV; O'Brien TA; Reed D; Spero JA; Lewis JH
    AIDS Res Hum Retroviruses; 1988 Jun; 4(3):223-31. PubMed ID: 3165003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation.
    Saah AJ; Farzadegan H; Fox R; Nishanian P; Rinaldo CR; Phair JP; Fahey JL; Lee TH; Polk BF
    J Clin Microbiol; 1987 Sep; 25(9):1605-10. PubMed ID: 3477569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Western blot (immunoblot) based on recombinant-derived p41 with conventional tests for serodiagnosis of human immunodeficiency virus infections.
    Hofbauer JM; Schulz TF; Hengster P; Larcher C; Zangerle R; Kofler H; Fritsch P; Wachter H; Dierich MP
    J Clin Microbiol; 1988 Jan; 26(1):116-20. PubMed ID: 3277988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A; Tanaka-Taya K; Ueda S
    Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A STLV-III related human retrovirus, HTLV-IV: analysis of cross-reactivity with the human immunodeficiency virus (HIV).
    Barin F; Denis F; Baillou A; Leonard G; Mounier M; M'Boup S; Gershy-Damet G; Sangare A; Kanki P; Essex M
    J Virol Methods; 1987 Aug; 17(1-2):55-61. PubMed ID: 2444614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody.
    Thorn RM; Beltz GA; Hung CH; Fallis BF; Winkle S; Cheng KL; Marciani DJ
    J Clin Microbiol; 1987 Jul; 25(7):1207-12. PubMed ID: 3475281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confirmation and differentiation of antibodies to human immunodeficiency virus 1 and 2 with a strip-based assay including recombinant antigens and synthetic peptides.
    Pollet DE; Saman EL; Peeters DC; Warmenbol HM; Heyndrickx LM; Wouters CJ; Beelaert G; van der Groen G; Van Heuverswyn H
    Clin Chem; 1991 Oct; 37(10 Pt 1):1700-7. PubMed ID: 1914169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sera from patients with multiple sclerosis react with human cell T lymphotropic virus-I gag proteins but not env proteins--Western blotting analysis.
    Ohta M; Ohta K; Mori F; Nishitani H; Saida T
    J Immunol; 1986 Dec; 137(11):3440-3. PubMed ID: 3023483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes.
    Nair MP; Pottathil R; Heimer EP; Schwartz SA
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6498-502. PubMed ID: 3045818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.